MLTX - CIK 0001821586
MoonLake Immunotherapeutics has filed 296 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Annual report | 10-K | 2024-02-29 | 2023-12-31 |
| Major company event | 8-K | 2024-02-29 | 2024-02-29 |
| Insider trade | 4 | 2024-02-29 | 2024-02-27 |
| Insider trade | 4 | 2024-02-29 | 2024-02-27 |
| Major company event | 8-K | 2024-02-26 | 2024-02-26 |
| Insider trade | 4 | 2024-02-23 | 2024-02-21 |
| Insider trade | 4 | 2024-02-22 | 2024-02-20 |
| Insider trade | 4 | 2024-02-20 | 2024-02-15 |
| Insider trade | 4 | 2024-02-16 | 2024-02-14 |
| Insider sale notice | 144 | 2024-02-15 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-15 | - |
| Insider sale notice | 144 | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-09 | - |
| Insider trade | 4 | 2023-12-21 | 2023-12-19 |
| Insider sale notice | 144 | 2023-12-20 | - |
| Insider sale notice | 144 | 2023-12-19 | - |
| Quarterly report | 10-Q | 2023-11-14 | 2023-09-30 |
| Major company event | 8-K | 2023-11-14 | 2023-11-14 |
| Major company event | 8-K | 2023-11-06 | 2023-11-05 |
| Major company event | 8-K | 2023-10-16 | 2023-10-15 |
| Insider trade | 4 | 2023-10-10 | 2023-10-05 |
| Insider trade | 4 | 2023-10-04 | 2023-10-02 |
| Insider trade | 4 | 2023-10-03 | 2023-10-01 |
| Insider trade | 4 | 2023-10-03 | 2023-10-01 |
| Insider trade | 4 | 2023-10-03 | 2023-10-01 |
| Insider trade | 4 | 2023-10-03 | 2023-10-01 |
| EFFECT | - | 2023-09-11 | - |
| Major company event | 8-K | 2023-09-11 | 2023-09-11 |
| Company correspondence | CORRESP | 2023-09-07 | - |
| SEC correspondence | UPLOAD | 2023-09-06 | - |
| Major company event | 8-K | 2023-09-01 | 2023-08-30 |
| Securities registration | S-3 | 2023-08-31 | - |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Insider trade | 4 | 2023-07-05 | 2023-06-30 |
| Activist ownership stake (update) | SC 13D/A | 2023-06-30 | - |
| Major company event | 8-K | 2023-06-29 | 2023-06-27 |
| Prospectus supplement | 424B5 | 2023-06-29 | - |
| Insider trade | 4 | 2023-06-28 | 2023-06-26 |
| 424B3 | - | 2023-06-27 | - |
| Prospectus supplement | 424B5 | 2023-06-26 | - |
| Major company event | 8-K | 2023-06-26 | 2023-06-26 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |